How to Sell a Veterinary Practice: The 2026 Guide to Multiples, Buyers, and Process

Selling a veterinary practice in 2026 is one of the highest-multiple M&A processes in all of healthcare. Multiples reach 8-15x EBITDA (vs 4-8x for most medical specialties) because: pets are non-discretionary spending, the sector has been heavily PE-consolidated since 2015, multi-doctor practices command premium pricing, and there are 5+ competing platforms in most major metros. For vet-owners considering sale, the market is structurally favorable.

This guide covers the practical sale process: 2026 multiples, the buyer landscape (Mars-owned platforms + independent consolidators), regulatory considerations, 12-month preparation playbook, and post-close transition expectations. Veterinary has become the gold standard PE roll-up case study — the consolidation that worked. Mars Inc. acquired Banfield (1,500+ hospitals) in 2007 and VCA (800+ hospitals) in 2017, becoming the dominant force. NVA, BluePearl, Pathway, and dozens of regional consolidators compete actively for new acquisitions.

“Veterinary is the highest-multiple sector in healthcare M&A — and the demand from PE consolidators isn’t slowing. A clean 3-vet practice today commands what a 10-physician medical practice did 5 years ago.”

Key Takeaways

• Vet practice multiples 2026: 8-15x EBITDA — highest in healthcare M&A.
• Active buyers: Mars (owns Banfield + VCA, 3,000+ hospitals total), NVA, BluePearl, Pathway Vet Alliance, MedVet, regional consolidators.
• Why high multiples: non-discretionary pet spending (75% US household ownership), growing pet insurance penetration, specialty/ER premium pricing.
• Preparation 12-18 months pre-sale produces 20-40% higher valuation.
• Critical valuation drivers: associate veterinarian productivity, specialty mix (general practice vs emergency vs specialty), real estate ownership, technology systems.
• Process timeline: 6-12 months from advisor engagement to close (faster than medical due to less regulatory complexity).
• Post-close: founder typically remains 2-4 years as Medical Director + equity holder in consolidator platform.
• Staff retention is critical: veterinary tech shortage means staff continuity affects valuation.

Veterinary practice valuation: 2026 multiples

For 2026 how to sell a veterinary specialty hospital with 10x-18x EBITDA and named buyers (Mars/VCA, BluePearl, Thrive, NVA, MedVet, Ethos), see our reference guide.

For 2026 veterinary practice acquisition playbook with 4x-12x range, corporate consolidator competition (Mars, NVA, Pathway), and SBA 7(a) financing, see our guide.

Vet multiples are the highest in healthcare M&A. Below are 2026 typical ranges by practice type and size.

The veterinary consolidation landscape

Vet consolidation has been the most successful healthcare PE roll-up case study. Mars Inc. dominates with Banfield + VCA + BluePearl (3,000+ hospitals globally). NVA (National Veterinary Associates) is the largest independent at ~1,500 hospitals. Below are the major 2026 players.

• Mars Veterinary Health. Combined Banfield (~1,500 GP hospitals), VCA (~800 GP), BluePearl (~150 specialty), AniCura (~500 European), Linnaeus (~150 UK). Dominant force in vet consolidation.
• NVA (National Veterinary Associates). ~1,500 hospitals, owned by JAB Holding Company. Aggressive acquisition strategy.
• Pathway Vet Alliance. ~250 hospitals, TSG Consumer Partners-backed. Focus on practice partnership model.
• MedVet. ~30+ specialty/ER hospitals, Compass Diversified-backed. Premium specialty focus.
• PetVet Care Centers. ~450 hospitals, KKR-backed. Mid-market roll-up.
• Heartland Veterinary Partners. ~200 hospitals, Audax Group-backed.
• Innovetive Petcare. Boutique roll-up focused on Texas/Southwest.
• SVP (Southern Veterinary Partners). ~300 hospitals, Shore Capital + Sentinel Capital-backed. South/Southeast focused.
• Regional consolidators. Dozens of smaller PE-backed regional players (Encore Vet Group, AlliedVet, Vetcor, others).

Why vet multiples are so high

Five structural factors drive premium vet valuations. These haven’t shown signs of changing in 2026.

1. Non-discretionary pet spending. 75% of US households own pets; pet-care spending grows 5-8% annually regardless of economic cycles. Recession-resistant.
2. Pet insurance growth. Insurance penetration up from 1.5M policies (2010) to 6M+ (2024). Insurance enables higher-cost procedures and reduces price sensitivity.
3. Specialty/ER premium pricing. Emergency and specialty hospitals charge 2-5x general-practice rates. Multi-specialty platforms command highest multiples.
4. 5+ active consolidators in most metros. Competitive bidding drives multiples up. Single-bidder scenarios rare.
5. Workforce shortage = premium for retention. Veterinarians and vet techs are scarce; practices with strong retention command premium. Buyer pays extra for stable team.

Buyer types and what each offers

Three buyer-type categories acquire vet practices. Each has different process and valuations.

Pre-sale preparation: 12-month playbook

Vet practice valuation is heavily dependent on preparation quality. Below is the canonical 12-month playbook.

The vertical-specific prep sequence is covered on our veterinary practice exit-planning walkthrough.

1. 12-18 months out: Engage healthcare M&A advisor experienced in vet sector. Optimize associate productivity (target 1,200-1,800 collections/year per FTE vet). Audit Medical Director succession planning.
2. 9-12 months out: Document referral relationships, customer retention rates, repeat-customer percentage. Address staff retention (vet tech shortage is major valuation driver). Implement clean Chart of Accounts separating owner-discretionary expenses.
3. 6-9 months out: Engage healthcare M&A attorney. Address pending litigation, state licensure issues. Sell-side QoE for $3M+ EBITDA practices.
4. 3-6 months out: Marketing teaser/CIM preparation. Initial outreach to PE-backed consolidators + regional roll-ups.
5. 3-0 months out: LOI process. Diligence. Negotiate post-close employment terms and Medical Director role.
6. Close-day: Transition. Employment agreement begins. Equity rollover funded.

Post-close: what vet-owners can expect

Post-close path varies by buyer. PE-backed consolidators offer the highest multiples but require post-close commitments.

• Medical Director role. Vet-owner typically becomes Medical Director of the acquired practice. 2-4 year employment commitment standard. Compensation: salary + production bonus + platform equity.
• Platform equity. Rollover typically 10-20% of consideration into platform equity. Tax-deferred via §351 rollover. Vests over 3-5 years.
• Operational changes. Mars/NVA/etc. impose technology and process standardization (Cornerstone PMS, branded service offerings, centralized purchasing). Some cultural disruption.
• Staff retention. Buyer typically retains all clinical staff; offers retention bonuses for vet techs and assistants. Administrative staff sometimes reduced as platform takes over back-office.

Critical valuation drivers

Six factors move vet practice multiples within the 8-15x range. Optimizing these 12-24 months pre-sale produces material valuation gains.

1. Number of FTE vets. 1-2 vets: 5-8x. 3-5 vets: 8-12x. 5+ vets multi-location: 10-14x. Scale = premium.
2. Specialty mix. General practice base + specialty referrals + ER capability commands premium over single GP.
3. Per-vet productivity. Target $1.2-1.8M collections/year per FTE. Above-median productivity adds 0.5-1.5x to multiple.
4. Real estate ownership. Practice + real estate often sold separately (sale-leaseback adds value).
5. Technology systems. Modern PMS (Cornerstone, ezyVet, IDEXX integration), digital imaging, in-house labs all add value.
6. Customer retention. 70%+ repeat-customer percentage signals loyal client base; below 50% raises concerns.

Common vet practice sale mistakes

Five recurring mistakes destroy value in vet practice sales. Each is correctable with preparation.

• Selling at peak owner-vet productivity without succession plan. If you produce 40%+ of practice collections, buyers discount heavily for transition risk.
• Not running competitive process. Bilateral with one consolidator typically produces 20-30% lower outcome. Engage 4-6 buyers minimum.
• Overlooking real estate value. Practice + real estate sold as bundle typically undervalues real estate by 15-25%. Sell-leaseback structure adds value.
• Inadequate staff retention planning. Top vet techs and associates leaving during transition reduces post-close value (and triggers earnout clawbacks).
• Aggressive add-back schedule. Vet practices have unique add-back conventions (owner’s personal pets, equipment depreciation timing). Use vet-experienced advisor.

Independent vs platform: is selling right for you?

Some vets resist PE consolidation and remain independent. The right answer depends on age, location, and personal priorities.

• Sell when: 5-10 years from retirement, want partial liquidity + continued work, located in PE-active region (most metros qualify), willing to give up day-to-day operational autonomy.
• Stay independent when: 15+ years to retirement, mid-career, willing to remain operator + administrator, in geographic area with limited consolidator activity, prefer ownership culture.
• Wait and see: 5-10 year horizon, monitor consolidator activity in your specialty/region, optimize for eventual sale, build platform equity.

Specialty vs GP: pricing differences

Specialty and ER hospitals command higher multiples than general practice. Below are 2026 typical ranges.

Conclusion

Veterinary practices command the highest multiples in healthcare M&A. 8-15x EBITDA in 2026 (vs 4-8x for most medical specialties) reflects: non-discretionary pet spending, growing insurance penetration, specialty premium pricing, and 5+ competing consolidators in most metros. Preparation 12-18 months pre-sale produces 20-40% higher proceeds. CT Acquisitions works with PE-backed vet consolidators — the buyer pays our fee at close.

Frequently Asked Questions

How much is a veterinary practice worth?

2026 typical multiples: single-vet GP 5-7x EBITDA, 3-vet GP 8-10x, 5+ vet GP multi-location 10-12x, emergency-only 10-13x, specialty 11-14x, multi-specialty hospital 13-16x. Vet multiples are the highest in healthcare M&A due to non-discretionary pet spending, growing insurance penetration, and aggressive PE consolidation since 2015.

Who buys veterinary practices?

Three primary buyer types: (1) PE-backed consolidators — Mars (owns Banfield + VCA + BluePearl, 3,000+ hospitals), NVA (~1,500), Pathway, MedVet, PetVet, Heartland, SVP, regional players. (2) Larger independent practices — geographic-fit acquirers. (3) Other vet investors — small specialty deals. PE-backed consolidators pay highest multiples; larger independents pay less but offer ownership structures.

What buyer pays the highest multiple for vet practices?

PE-backed national consolidators (Mars Veterinary Health, NVA, Pathway Vet Alliance, MedVet for specialty/ER). 10-14x EBITDA typical for 3+ vet platforms; specialty/ER hospitals reach 13-16x. Regional consolidators slightly lower (8-11x). Independent larger practices lowest (5-8x). Run a competitive process with 4-6 buyers minimum.

How long does it take to sell a vet practice?

6-12 months from advisor engagement to close, faster than medical practice sales due to less regulatory complexity. Stages: 1-2 months marketing prep + 1-2 months LOI process + 2-3 months due diligence + 1-2 months close logistics. Preparation 6-12 months pre-engagement adds another 6-12 months but materially improves valuation.

What is Mars Veterinary Health?

Mars Inc. (the candy/pet food conglomerate) owns the largest veterinary platform in the world. Acquired Banfield Pet Hospital (1,500+ GP hospitals) in 2007, VCA Inc. (800+ GP hospitals) in 2017, BluePearl (150+ specialty hospitals) plus international platforms AniCura and Linnaeus. Total: ~3,000+ hospitals globally. Mars Vet Health is the dominant force in vet consolidation.

What is NVA (National Veterinary Associates)?

NVA is the largest independent (non-Mars) vet consolidator with ~1,500 hospitals. Owned by JAB Holding Company (also owns Krispy Kreme, Panera, Peet’s Coffee). Aggressive acquisition strategy with strong cultural fit reputation. Acquired by JAB from Ares Management in 2019.

Should I sell my vet practice now or wait?

Generally favorable to sell now. Multiples have remained at peak levels through 2024-2025 despite broader M&A multiple compression. Pet spending continues to grow regardless of economic cycles. Specialty/ER continues consolidating with premium multiples. Wait only if you’re: (1) mid-career with 15+ years to retirement, (2) in a region with limited consolidator activity, or (3) need 2-3 years to optimize practice for higher multiple.

What’s the difference between selling to Mars vs an independent consolidator?

Mars Veterinary Health (Banfield/VCA): largest scale, established processes, branded customer experience, higher employee benefits, but more standardization. Independent consolidators (NVA, Pathway, regional players): more practice autonomy, often partnership-equity models, less branded customer experience. Multiples are similar across major platforms (10-13x EBITDA for quality GP practices).

Do I have to stay after selling my vet practice?

Yes, typically 2-4 years as Medical Director with employment agreement + platform equity. Standard structure: base salary + production bonus + 10-20% equity rollover (tax-deferred via §351). Equity vests over 3-5 years. After commitment, you can typically transition to consulting or fully exit. Some platforms offer earlier exit for senior vets (5+ years to retirement).

How can I maximize my vet practice valuation?

Six levers: (1) Build multi-vet scale (3+ FTE vets minimum, 5+ ideal). (2) Optimize per-vet productivity to $1.2-1.8M collections. (3) Add specialty/ER capability if practical. (4) Document referral patterns and customer retention rates. (5) Implement modern PMS (Cornerstone, ezyVet) and digital imaging. (6) Address staff retention proactively — vet tech shortage means staff continuity affects valuation.

What about my real estate?

Sell separately via sale-leaseback structure. Vet practice + real estate bundled together typically undervalues the real estate by 15-25%. Optimal: practice sells at EBITDA multiple to consolidator; real estate sells at cap-rate basis to separate REIT or real estate investor; consolidator leases facility on long-term lease (10-15 years, NNN). Adds 15-25% to total seller proceeds.

Why work with CT Acquisitions on a vet practice sale?

CT Acquisitions works with PE-backed vet consolidators actively acquiring practices. We can introduce you to specific platforms most likely to fit your practice (geography, size, specialty). The buyer pays our fee at close — the seller pays nothing. No exclusivity, no contracts. Most engagements close in 8-12 months.